GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Anagenics Ltd (OTCPK:CELMF) » Definitions » EBITDA Margin %

Anagenics (Anagenics) EBITDA Margin % : -16.71% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Anagenics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Anagenics's EBITDA for the six months ended in Dec. 2023 was $-0.70 Mil. Anagenics's Revenue for the six months ended in Dec. 2023 was $4.17 Mil. Therefore, Anagenics's EBITDA margin for the quarter that ended in Dec. 2023 was -16.71%.


Anagenics EBITDA Margin % Historical Data

The historical data trend for Anagenics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anagenics EBITDA Margin % Chart

Anagenics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -72.81 -57.28 -55.94 -33.34 -14.73

Anagenics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.84 -32.10 -5.84 -26.27 -16.71

Competitive Comparison of Anagenics's EBITDA Margin %

For the Household & Personal Products subindustry, Anagenics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anagenics's EBITDA Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Anagenics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Anagenics's EBITDA Margin % falls into.



Anagenics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Anagenics's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-0.901/6.116
=-14.73 %

Anagenics's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.697/4.171
=-16.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anagenics  (OTCPK:CELMF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Anagenics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Anagenics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Anagenics (Anagenics) Business Description

Traded in Other Exchanges
Address
55 Clarence Street, Suite 204, Level 2, Sydney, NSW, AUS, 2000
Anagenics Ltd has evolved into a growing beauty, health, and wellness business with a portfolio of functional skin, hair, and wellness brands. It develops and sells differentiated and clinically validated solutions for a range of conditions associated with aging. It includes validated consumer products to help people live longer, in good health, and with confidence. Its brands include Evolis and Uspa.

Anagenics (Anagenics) Headlines

No Headlines